121 related articles for article (PubMed ID: 31839058)
1. [Effect of Pomalidomide on Activity of Myeloma Cell Line MM1.S and Expression of CRBN].
Fan WJ; Fan ZQ; Pan YZ; Yang K; Yin JJ; Zhao XC; Yao H; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1907-1911. PubMed ID: 31839058
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide screening reveals a role for subcellular localization of CRBN in the anti-myeloma activity of pomalidomide.
Tateno S; Iida M; Fujii S; Suwa T; Katayama M; Tokuyama H; Yamamoto J; Ito T; Sakamoto S; Handa H; Yamaguchi Y
Sci Rep; 2020 Mar; 10(1):4012. PubMed ID: 32132601
[TBL] [Abstract][Full Text] [Related]
3. A novel effect of thalidomide and its analogs: suppression of cereblon ubiquitination enhances ubiquitin ligase function.
Liu Y; Huang X; He X; Zhou Y; Jiang X; Chen-Kiang S; Jaffrey SR; Xu G
FASEB J; 2015 Dec; 29(12):4829-39. PubMed ID: 26231201
[TBL] [Abstract][Full Text] [Related]
4. Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.
Lopez-Girona A; Mendy D; Ito T; Miller K; Gandhi AK; Kang J; Karasawa S; Carmel G; Jackson P; Abbasian M; Mahmoudi A; Cathers B; Rychak E; Gaidarova S; Chen R; Schafer PH; Handa H; Daniel TO; Evans JF; Chopra R
Leukemia; 2012 Nov; 26(11):2326-35. PubMed ID: 22552008
[TBL] [Abstract][Full Text] [Related]
5. Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs.
Lindner S; Steinebach C; Kehm H; Mangold M; Gütschow M; Krönke J
J Vis Exp; 2019 May; (147):. PubMed ID: 31157769
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma.
Ma J; Wang S; Zhao M; Deng XS; Lee CK; Yu XD; Liu B
BMC Cancer; 2011 Jun; 11():255. PubMed ID: 21679466
[TBL] [Abstract][Full Text] [Related]
7. Cereblon gene expression and correlation with clinical outcomes in patients with relapsed/refractory multiple myeloma treated with pomalidomide: an analysis of STRATUS.
Qian X; Dimopoulos MA; Amatangelo M; Bjorklund C; Towfic F; Flynt E; Weisel KC; Ocio EM; Yu X; Peluso T; Sternas L; Zaki M; Moreau P; Thakurta A
Leuk Lymphoma; 2019 Feb; 60(2):462-470. PubMed ID: 30068263
[TBL] [Abstract][Full Text] [Related]
8. Selective Degradation of GSPT1 by Cereblon Modulators Identified via a Focused Combinatorial Library.
Powell CE; Du G; Che J; He Z; Donovan KA; Yue H; Wang ES; Nowak RP; Zhang T; Fischer ES; Gray NS
ACS Chem Biol; 2020 Oct; 15(10):2722-2730. PubMed ID: 32865967
[TBL] [Abstract][Full Text] [Related]
9. PLZF and its fusion proteins are pomalidomide-dependent CRBN neosubstrates.
Shimizu N; Asatsuma-Okumura T; Yamamoto J; Yamaguchi Y; Handa H; Ito T
Commun Biol; 2021 Nov; 4(1):1277. PubMed ID: 34764413
[TBL] [Abstract][Full Text] [Related]
10. Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4.
Bjorklund CC; Lu L; Kang J; Hagner PR; Havens CG; Amatangelo M; Wang M; Ren Y; Couto S; Breider M; Ning Y; Gandhi AK; Daniel TO; Chopra R; Klippel A; Thakurta AG
Blood Cancer J; 2015 Oct; 5(10):e354. PubMed ID: 26430725
[TBL] [Abstract][Full Text] [Related]
11. Lenalidomide affect expression level of cereblon protein in multiple myeloma cell line RPMI8226.
Yang DY; Ren JH; Guo XN; Guo XL; Cai XY; Guo XF; Zhang JN
Genet Mol Res; 2015 Oct; 14(4):13588-94. PubMed ID: 26535672
[TBL] [Abstract][Full Text] [Related]
12. Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD immunomodulatory drug pomalidomide.
Das DS; Ray A; Song Y; Richardson P; Trikha M; Chauhan D; Anderson KC
Br J Haematol; 2015 Dec; 171(5):798-812. PubMed ID: 26456076
[TBL] [Abstract][Full Text] [Related]
13. [Ribosomal Protein S9 Expression in Multiple Myeloma and Its Effect on Cell Biological Function].
Song KP; Shu P; Ma JL; Wang B; Chen B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Apr; 41(2):175-182. PubMed ID: 31060671
[TBL] [Abstract][Full Text] [Related]
14. Homo-PROTACs for the Chemical Knockdown of Cereblon.
Steinebach C; Lindner S; Udeshi ND; Mani DC; Kehm H; Köpff S; Carr SA; Gütschow M; Krönke J
ACS Chem Biol; 2018 Sep; 13(9):2771-2782. PubMed ID: 30118587
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cereblon levels by anti-myeloma agents.
Díaz-Rodríguez E; Pandiella A
Leuk Lymphoma; 2016; 57(1):167-76. PubMed ID: 25860244
[TBL] [Abstract][Full Text] [Related]
16. [Effect of 20 (S)-ginsenoside Rg3 on the proliferation inhibition and secretion of vascular endothelial growth factor of multiple myeloma cell line U266].
Song Y; Hou J; Kang L; Gao S
Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):519-23. PubMed ID: 24985176
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory Effect of Resveratrol on the Proliferation of Multiple Myeloma Cells and the Underlying Mechanism].
Zhou N; Cao SX; Wang ZZ; Luo JM; Liu XJ; Shang YT; Yang L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1093-1099. PubMed ID: 37551482
[TBL] [Abstract][Full Text] [Related]
18. [TLR4 signals are involved in multiple myeloma cell proliferation and apoptosis].
Bao HY; Wang LJ; Yang Y; Cai Z
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 38(5):465-9. PubMed ID: 19830858
[TBL] [Abstract][Full Text] [Related]
19. Aspirin inhibits proliferation and induces apoptosis of multiple myeloma cells through regulation of Bcl-2 and Bax and suppression of VEGF.
Ding JH; Yuan LY; Huang RB; Chen GA
Eur J Haematol; 2014 Oct; 93(4):329-39. PubMed ID: 24766194
[TBL] [Abstract][Full Text] [Related]
20. [The Effects of Chidamide Combined with Anti-myeloma Drugs on the Proliferation and Apoptosis of Myeloma Cells].
Liu Y; Xu Y; Xie Y; Chen GH; Liu W; Yao WQ; Yan S; Yan LZ; Wu DP; Fu CC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1187-1194. PubMed ID: 34362501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
